Pine Valley Investments Ltd Liability Co Cuts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Pine Valley Investments Ltd Liability Co reduced its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 35.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,386 shares of the biotechnology company’s stock after selling 2,413 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in Axon Enterprise were worth $2,607,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. Prestige Wealth Management Group LLC increased its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $40,000. Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $41,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $45,000. Finally, Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Down 0.6 %

Shares of NASDAQ:AXON opened at $496.65 on Wednesday. Axon Enterprise, Inc. has a 1-year low of $265.32 and a 1-year high of $715.99. The stock has a market cap of $37.87 billion, a P/E ratio of 128.33, a P/E/G ratio of 5.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a fifty day moving average price of $614.17 and a 200 day moving average price of $521.71.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on AXON shares. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,711 shares of company stock worth $5,631,561. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.